62 studies found for:    hypercoagulation OR thrombophilia OR blood clotting | Open Studies | NIH, U.S. Fed
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Condition: HIV
2 Recruiting The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
Condition: Glanzmann Thrombasthenia
3 Recruiting Understanding the Role of Genes and Biomarkers in the Blood Clotting Process in Children With Acute Lung Injury
Condition: Respiratory Distress Syndrome, Adult
4 Recruiting ART and Inflammatory and Coagulation Biomarkers
Conditions: HIV (Human Immunodeficiency Virus);   AIDS (Acquired Immune Deficiency Syndrome);   Tuberculosis;   Non-communicable Diseases (NCD)
5 Recruiting Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT)
Conditions: Heart Failure;   Respiratory Failure
6 Recruiting The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Condition: HIV
Interventions: Drug: Ritonavir;   Drug: Cobicistat
7 Recruiting Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.
Condition: Colon Polyps
Intervention: Procedure: Clip closure
8 Recruiting Targeting Platelets in Chronic HIV Infection
Condition: HIV-1 Infection
Interventions: Drug: Clopidogrel;   Drug: Aspirin;   Drug: Placebo
9 Recruiting Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Conditions: Anal Cancer;   High-grade Squamous Intraepithelial Lesion;   HIV Infection;   Human Papilloma Virus Infection
Interventions: Drug: imiquimod;   Drug: fluorouracil;   Procedure: infrared photocoagulation therapy;   Procedure: thermal ablation therapy;   Procedure: laser therapy;   Other: clinical observation;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
10 Not yet recruiting Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Conditions: Deep Vein Thrombosis;   Malignant Neoplasm;   Portal Vein Thrombosis;   Pulmonary Embolism;   Renal Vein Thrombosis;   Venous Thromboembolism
Interventions: Drug: Apixaban;   Drug: Dalteparin;   Other: Questionnaire Administration
11 Recruiting Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets
Condition: Thrombocytopenia
Interventions: Biological: CPP;   Biological: LSP
12 Recruiting The Interaction of Social Factors With Air Pollution
Condition: Exposure to Environmental Pollution, Non-occupational
Interventions: Other: Clean Air;   Other: Ozone
13 Recruiting Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
Condition: HIV Infection
Interventions: Drug: Aspirin 81 mg daily;   Drug: Atorvastatin 40 mg daily
14 Recruiting Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Condition: Coronary Artery Bypass
Interventions: Drug: Prasugrel;   Drug: Placebo
15 Recruiting Personalized Medicine Decision-Making in a Virtual Clinical Setting
Conditions: Deep Vein Thrombosis;   Blood Clots
16 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group
17 Recruiting Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Biological: rituximab
18 Recruiting Control of Major Bleeding After Trauma Study
Conditions: Trauma;   Hemorrhagic Shock
Interventions: Biological: Type AB plasma;   Drug: Crystalloid fluid (standard of care for resuscitation)
19 Unknown  Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Conditions: Sepsis;   Septicemia;   Sepsis Syndrome;   Shock, Septic;   Community Acquired Pneumonia
20 Recruiting Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints
Condition: HIV
Interventions: Drug: vorapaxar;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years